Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

EXPAND
Expand Energy Names Danny Brown as New CEO

Expand Energy Corporation has appointed Daniel E. Brown as President and Chief Executive Officer, succeeding Michael Wichterich, following an extensiv...

CERTIOR
13F-HR - CERTIOR FINANCIAL GROUP, LLC (0002055620) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by CERTIOR FINANCIAL GROUP, LLC....

ArriVent
ArriVent reports publication of firmonertinib in EGFR PACC-mutant NSCLC.

ArriVent BioPharma announced positive preclinical and clinical results from the FURTHER Phase 1b trial of firmonertinib for advanced EGFR PACC-mutant ...

MATTEL
Mattel appoints Chief Financial Officer

Mattel Inc. announced the appointment of Peter Griffith as its new Chief Financial Officer and Board member, with an expected October 20 offer accepta...

Silence
Silence Therapeutics enters definitive agreement to be acquired by Merck KGaA

Silence Therapeutics plc has executed a definitive transaction agreement to be acquired by Merck KGaA, Darmstadt, Germany, in a scheme of arrangement ...

Clene
Clene submits NDA for ALS treatment candidate.

Clene Inc. filed a New Drug Application with the FDA seeking accelerated approval of CNM-Au8 for ALS, a significant regulatory milestone for the compa...

DYNEX
Dynex Capital Q3 2026 Results Include Total Economic Return of $(1.48) Per Share

Dynex Capital reported total economic returns of $(1.48) per share for Q3 2026, reflecting a decrease in book value. Management highlighted opportunit...

CorMedix
CorMedix Announces FDA Priority Review for REZZAYO S-NDA

The FDA accepted the supplemental NDA with a target action date of Q1 2027, supported by the ReSPECT Phase III trial. This milestone marks a significa...

Super
Super League stockholders approve Metaplanet Bitcoin investment

Stockholders approved all proposals, including a strategic $170M Bitcoin and cash investment by Metaplanet. Post-closing, Super League will be renamed...

Acorn
13F-HR - Acorn Wealth Advisors, LLC (0001730610) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Acorn Wealth Advisors, LLC....

Advantage
Advantage Solutions Amends and Restates Its Bylaws

Advantage Solutions Inc. has filed its Fourth Amended and Restated Bylaws, effective upon adoption. This governance update clarifies internal procedur...

CENTRUS
Centrus Energy Corp Announced Agreement to Purchase Westerman Holdings, LLC

Centrus Energy Corp announced an agreement to purchase Westerman Holdings, LLC to align operations and strengthen energy capabilities....

PensionDanmark
13F-HR - PensionDanmark Pensionsforsikringsaktieselskab (0001897090) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by PensionDanmark Pensionsforsikringsaktieselskab....

SILGAN
Silgan Announces Strategic Acceleration via Partnership with AIP to form Divestiture Transaction

Silgan Holdings is forming a partnership with American Industrial Partners to combine its Metal Packaging and Closures businesses into a new entity, S...

NEWS
News Corp announces buyback program

News Corporation filed an Appendix 3C to announce a buyback program for Class A Common Stock. The notification was filed to update a previous announce...

FirstEnergy
FirstEnergy PA Electric Extends Exchange Offer Notes

FirstEnergy PA Electric extended its exchange offer for senior notes due 2028 and 2031, previously set to expire October 16, 2026....

EquipmentShare.com
EquipmentShare Increases 2026 Revenue Guidance to 43% Growth

EquipmentShare raised its full-year rental revenue outlook to $3.823B-$3.979B, citing strong demand and rationalizing its long-term Core EBITDA potent...

Marker
Marker lands FDA grant worth $2.6M for pancreatic cancer program

Marker Therapeutics secured a $2.6 million FDA grant to fund a Phase 1 trial of its lead therapy MT-601, representing financial validation for its lon...

ZENITH
13F-HR - ZENITH SOLUTIONS, INC. (0001948435) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by ZENITH SOLUTIONS, INC.....

Disc
Disc Medicine Announces Bitopertin Met All Endpoints in APOLLO Phase 3 Trial for EPP

Disc Medicine announced bitopertin met all primary and secondary endpoints in the APOLLO Phase 3 trial for erythropoietic protoporphyria, signaling a ...